What is Callyope?
Based in France, Callyope operates at the intersection of clinical medicine and advanced data analytics. The company specializes in the development of sophisticated remote patient monitoring systems designed specifically to address the complexities of mental health care. By leveraging real-time data, Callyope provides clinicians with actionable insights, effectively bridging the gap between episodic care and continuous patient oversight. Its market position is defined by a commitment to improving patient outcomes through scalable, technology-driven interventions that integrate seamlessly into existing healthcare workflows.
The firm's strategic focus on mental health places it in a high-growth segment of the digital health market, where the demand for objective, data-backed diagnostic and monitoring tools is rapidly increasing. By digitizing the patient experience, Callyope is not only enhancing the quality of care but also optimizing the efficiency of mental health service delivery for providers across the region.
How much funding has Callyope raised?
Callyope has raised a total of $2.4M across 1 funding round:
Other Financing Round
$2.4M
Other Financing Round (2023): $2.4M with participation from 360 Capital Partners, Bpifrance, and No Label Ventures
Key Investors in Callyope
360 Capital Partners
A venture capital firm focused on innovation across Europe, particularly in France and Italy, with a strong track record of supporting companies through various growth stages.
Bpifrance
A French public investment bank that provides credit, guarantees, and equity to support the development and international expansion of innovative companies.
No Label Ventures
Undisclosed investor participating in the funding round.
What's next for Callyope?
With the infusion of $2.4M, Callyope is entering a critical phase of enterprise-level scaling. The company is expected to prioritize the expansion of its clinical validation studies and the enhancement of its software-as-a-service (SaaS) platform capabilities. Future strategic initiatives will likely involve deepening its integration with hospital information systems and expanding its reach into broader European markets. As the company transitions from its current development stage to a more mature commercial phase, the focus will remain on maintaining regulatory compliance while scaling its infrastructure to support a larger volume of patient data. This capital deployment serves as a foundational element for the company's long-term objective of becoming a standard-bearer in the digital mental health monitoring space.
See full Callyope company page
